Table 1.
Preferred term | Placebo | ETOH, 0.5 g/kg | GSK152149,8 20 mg | GSK1521498 + ETOH at 1 hour | GSK1521498 + ETOH at 4 hours |
---|---|---|---|---|---|
Total subjects | 26 | 25 | 23 | 4 | 23 |
Any adverse event | 4 (15) | 11 (44) | 5 (22) | 4 (100) | 7 (30) |
Nausea | 1 (4) | 1 (4) | 2 (9) | 1 (25) | 3 (13) |
Dizziness | 0 | 4 (16) | 0 | 0 | 2 (9) |
Fatigue | 1 (4) | 0 | 2 (9) | 0 | 2 (9) |
Headache | 1 (4) | 0 | 1 (4) | 0 | 3 (13) |
Vomiting | 1 (4) | 0 | 1 (4) | 1 (25) | 1 (4) |
Tandem gait test abnormal | 0 | 2 (8) | 0 | 0 | 2 (9) |
Gait disturbance | 0 | 1 (4) | 0 | 2 (50) | 0 |
Coordination abnormal | 0 | 1 (4) | 0 | 1 (25) | 1 (4) |
Positive Rombergism | 0 | 2 (8) | 0 | 0 | 1(4) |
Feeling drunk | 0 | 1 (4) | 0 | 0 | 1 (4) |
Abdominal distension | 0 | 0 | 1 (4) | 0 | 1 (4) |
Somnolence | 0 | 0 | 0 | 1 (25) | 1 (4) |
Disturbance in attention | 0 | 0 | 0 | 0 | 2 (9) |
Skin irritation | 1 (4) | 0 | 1 (4) | 0 | 0 |
Euphoric mood | 0 | 1 (4) | 1 (4) | 0 | 0 |
Decreased appetite | 0 | 0 | 1 (4) | 0 | 1 (4) |